ARTICLE

FindCenter AddIcon

‘60 Minutes’ Segment Explores Psychedelics Research at Johns Hopkins

By 60 Minutes — 2019

Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.

Read on hub.jhu.edu

FindCenter Post-Image

In Light of Death

An interview with Rick Fields on living with cancer.

Article
Tricycle
1997
FindCenter AddIcon
FindCenter Post-Image

Death and Dying: Fuck You, Cancer

Rick Fields, poet, writer, and editor-in-chief of Yoga Journal, was diagnosed with inoperable lung cancer in 1995 at the age of 53.

Article
Dan Johnson and From The Futurist
1998
FindCenter AddIcon
FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Article
Michael Pollan
2018
FindCenter AddIcon
FindCenter Post-Image

Not So Fast on Magic Mushrooms

Only a few days ago, millions of Americans probably had never heard of psilocybin, the active agent in psychedelic mushrooms, but thanks to Denver, it is about to get its moment in the political sun.

Article
Michael Pollan
2019
FindCenter AddIcon
FindCenter Post-Image

Experiences of ‘Ultimate Reality’ or ‘God’ Confer Lasting Benefits to Mental Health

In a survey of thousands of people who reported having experienced personal encounters with God, researchers report that more than two-thirds of self-identified atheists shed that label after their encounter, regardless of whether it was spontaneous or while taking a psychedelic.

Article
Johns Hopkins Medicine
2019
FindCenter AddIcon
FindCenter Post-Image

Roland Griffiths: 5 Fast Facts You Need to Know

Roland Griffiths is a Johns Hopkins University professor, researcher and expert in the field of pharmacology. He is best known for his research into the beneficial effects psilocybin on cancer patients.

Article
Alyssa Choiniere
2019
FindCenter AddIcon
FindCenter Post-Image

DMT Models the Near-Death Experience

Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).

Article
Christopher Timmermann, Leor Roseman, Luke Williams, David Erritzoe, Charlotte Martial, Héléna Cassol, Steven Laureys, David Nutt and Robin Carhart-Harris
2018
FindCenter AddIcon
FindCenter Post-Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

Article
Amanda Feilding
2017
FindCenter AddIcon
FindCenter Post-Image

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Article
High Times
2020
FindCenter AddIcon

EXPLORE TOPIC

Psilocybin